![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 on Phase I/II Trial of Encorafenib, Cetuximab, & Nivolumab in Patients With MSS BRAFV600E mCRC
By
ASCO 2022 Conference Coverage
FEATURING
Van Morris
By
ASCO 2022 Conference Coverage
FEATURING
Van Morris
6 views
June 28, 2022
Login to view comments.
Click here to Login
GI